Alterity Therapeutics Limited
Imidazo [1,5-a]pyridine compounds and their use
Last updated:
Abstract:
The present invention provides compounds that modulate biological metals and to pharmaceutical compositions containing such compounds. The invention particularly relates to imidazo[1,5-a]pyridine compounds of formula (I) that modulate iron and are useful for the treatment of diseases, particularly neurological diseases such as Parkinson's disease (PD), Alzheimer's disease (AD), Alzheimer-type dementia, Huntington's disease (HD), amyotrophic lateral sclerosis (ALS), frontotemporal dementia (FTD) and multiple system atrophy (MSA). The compounds of formula (I) being ##STR00001## where variables are defined herein.
Status:
Grant
Type:
Utility
Filling date:
13 Mar 2020
Issue date:
9 Mar 2021